Monitoring mitochondrial inner membrane potential for detecting early changes in viability of bacterium-infected human bone marrow-derived mesenchymal stem cells-Reference-Cited by-同舟云学术

Monitoring mitochondrial inner membrane potential for detecting early changes in viability of bacterium-infected human bone marrow-derived mesenchymal stem cells

Published:2012-12 Issue:6 Volume:3 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

Pietilä Mika,Lähteenmäki Kaarina,Lehtonen Siri,Leskelä Hannu-Ville,Närhi Marko,Lönnroth Maarit,Mättö Jaana,Lehenkari Petri,Nordström Katrina

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

https://link.springer.com/content/pdf/10.1186/scrt144.pdf

Reference45 articles.

1. Chang F, Ishii T, Yanai T, Mishima H, Akaogi H, Ogawa T, Ochiai N: Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res. 2008, 26: 18-26. 10.1002/jor.20470.

2. Dumas A, Moreau MF, Gherardi RK, Basle MF, Chappard D: Bone grafts cultured with bone marrow stromal cells for the repair of critical bone defects: an experimental study in mice. J Biomed Mater Res A. 2009, 90: 1218-1229.

3. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Baciqalupo A, Fibbe W, Ringden O, Developmental Committee of the European Group for Blood and Marrow Transplant: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008, 371: 1579-1586. 10.1016/S0140-6736(08)60690-X.

4. Loewenbruck K, Storch A: Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?. J Neurol. 2011, 258: S346-353. 10.1007/s00415-011-5974-4.

5. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004, 364: 141-148. 10.1016/S0140-6736(04)16626-9.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotextured titanium inhibits bacterial activity and supports cell growth on 2D and 3D substrate: A co-culture study;Biomaterials Advances;2024-04

2. The ratio of nicotinic acid to nicotinamide as a microbial biomarker for assessing cell therapy product sterility;Molecular Therapy - Methods & Clinical Development;2022-06

3. Mechanisms of Interaction of Staphylococcus Aureus With Human Mesenchymal Stem Cells and Their Differentiated Phenotypes;2020-01-09

4. Pioglitazone Protects Compression-Mediated Apoptosis in Nucleus Pulposus Mesenchymal Stem Cells by Suppressing Oxidative Stress;Oxidative Medicine and Cellular Longevity;2019-11-22

5. Human Beta-Defensin-2 and -3 Mitigate the Negative Effects of Bacterial Contamination on Bone Healing in Rat Calvarial Defect;Tissue Engineering Part A;2018-04